The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

Authors: Brandon Essink, Laurence Chu, William Seger, Elizabeth Barranco, Nancy Le Cam, Hamilton Bennett, Veronica Faughnan, Rolando Pajón, Yamuna Devi Paila, Brooke Bollman, Steven Wang, Jacqueline Dooley, Shiva Kalidindi, Brett Leav - The Lancet 2023 cited by 141